FindTrial
Sign In

A COMPARISON BETWEEN TWO GROUPS WITH 0.5% BUPIVACAINE(LOCAL ANESTHETIC AGENT) AND 0.5% BUPIVACAINE WITH PENTAZOCINE,AN OPIOID ANALGESIC, AS AN ADDITIVE FOR POST OPERATIVE PAIN RELIEF IN UPPER LIMB SURGERY BY SUPRACLAVICULAR BRACHIAL PLEXUS NERVE BLOCK WHICH BLOCKS NERVE SUPPLY OF UPPER LIMB

A PROSPECTIVE,RANDOMISED, DOUBLE BLINDED COMPARATIVE STUDY BETWEEN 0.5% BUPIVACAINE AND 0.5% BUPIVACAINE WITH PENTAZOCINE AS AN ADJUVANT IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR POST OPERATIVE ANALGESIA IN UPPER LIMB SURGERY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026494
Enrollment
70
Registered
2020-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR POST OPERATIVE ANALGESIA IN UPPER LIMB SURGERY: SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK GIVEN WITH 19 ML OF 0.5 % BUPIVACAINE AND 1 ML OF PENTAZO

Sponsors

MIDNAPORE MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18-60 years 2. ASA grade 1 & 2 3. Elective upper limb Surgery under supraclavicular brachial plexus block

Exclusion criteria

Exclusion criteria: 1. Patients with history of Uncontrolled Diabetes-Mellitus Uncontrolled Hypertension Coagulopathy Liver disease Cardio pulmonary disease Renal insufficiency or failure Musculoskeletal disorder Drug and alcohol abuse 2. Pregnant patients 3. BMI more than 30 4. Allergy to bupivacaine or pentazocine 5. Conversion to general anesthesia 7. Brachial plexus block failure 8. Difficult airway 9. Surgeries with intraoperative time more than 2 hours. 10. Patient who received analgesic in the pre operative phase (within effective time range of that particular drug) 11. Unwilling to participate 12. Serology positive (HIV1&2,Hbs ag,Anti HCV), & immunocompromised patients

Design outcomes

Primary

MeasureTime frame
We are expecting that 0.5% bupivacaine with pentazocine as an adjuvant will increase duration of sensory and motor blockade and will provide better analgesia than 0.5% bupivacaine aloneTimepoint: Patientâ??s hemodynamic profile (like BP, heart rate, oxygen saturation etc), pain , and adverse effects will be monitored at base line, just after giving block then every 15 minutes intra operatively and every hour postoperatively for 8 hours.—

Secondary

MeasureTime frame
1. To compare the hemodynamic changes like Heart rate(HR), Systolic Blood Pressure(SBP), Diastolic Blood Pressure(DBP),Mean Arterial Pressure(MAP) intra and post operatively 2. To compare the side effects of pentazocine in supra clavicular brachial plexus block 3. Patientâ??s satisfaction 4. Surgeonâ??s satisfaction Timepoint: Patientâ??s hemodynamic profile (like BP, heart rate, oxygen saturation etc), pain , and adverse effects will be monitored at base line, just after giving block then every 15 minutes intra operatively and every hour postoperatively for 8 hours.—

Countries

India

Contacts

Public ContactARUN KUMAR MANDI

PROFESSOR AND HOD DEPARTMENT OF ANAESTHESIOLOGY IPGMER

ritapal1956@gmail.com9830418539

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026